Patents by Inventor Tage Honore

Tage Honore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
    Patent number: 4812458
    Abstract: Heterocyclic dihydroxyquinoxaline compounds having the formula ##STR1## wherein R.sup.1 is halogen, CN, CF.sub.3, ethynyl, or N.sub.3 andR.sup.2 is SO.sub.2 C.sub.1-3 -alkyl, CF.sub.3, NO.sub.2, ethynyl, or CN.The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use.The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters, particularly the quisqualate receptors, and especially as neuroleptics.
    Type: Grant
    Filed: September 2, 1987
    Date of Patent: March 14, 1989
    Assignee: A/S Ferrosan
    Inventors: Tage Honore, Jorgen Drejer, Poul Jacobsen, Flemming E. Nielsen
  • .beta.-carbolin-3-carboxylic acid derivatives and their use as benzodiazepine antagonists
    Patent number: 4748179
    Abstract: .beta.-carbolin-3-carboxylic acid derivatives of the general formula ##STR1## wherein R.sup.1 is methyl, ethyl, n-propyl or iso-propyl, and whereinR.sup.2 is hydrogen, methyl, ethyl, n-propyl or iso-propyl, provided that R.sup.1 is not methyl, when R.sup.2 is hydrogen, are produced by different methods.The compounds are useful in psychopharmaceutical preparations, being antagoinists of benzodiazepines.
    Type: Grant
    Filed: June 20, 1985
    Date of Patent: May 31, 1988
    Assignee: Schering Aktiengesellschaft
    Inventors: Claus T. Braestrup, Erling Petersen, Tage Honore, Leif H. Jensen, Dieter Seidelmann
  • .beta.-carboline-3-oxadiazolyl derivatives, and their use as psychotropic agents
    Patent number: 4645773
    Abstract: New .beta.-carboline-3-oxadiazolyl derivatives have the general formula I: ##STR1## wherein X is ##STR2## and wherein R.sup.4, R.sup.A and R have specified meanings. These new compounds exhibit surprising psychotropic properties.
    Type: Grant
    Filed: May 15, 1985
    Date of Patent: February 24, 1987
    Assignee: Schering Aktiengesellschaft
    Inventors: Mogens Engelstoft, Tage Honore, Frank Watjen, Erling N. Petersen, Andreas Huth